In addition, upregulated CCND2, SNHG16, MYC, and GNAS levels were associated with accelerating cell cycle progression, as well as promoting growth and metastasis in lung cancer, breast cancer, and colon cancer (Cai et al., 2017; Fallah et al., 2017; Teng et al., 2017; Batistatou et al., 2018; Hung et al., 2018; Han et al., 2019; Jin et al., 2019; SM, 2020). Here, CCND2 is linked to lung cancer.